BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 10 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding BioCardia, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 23 | 25 | +2 |
| Shares | 1.64M | 2.33M | +696.9K (+42.6%) |
| Value | $3.17M | $4.87M | +$1.70M (+53.6%) |
New holders (3)
Institutions that held BioCardia, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AIGH Capital Management LLC | 595,237 | $1.24M | 0.41% |
| Worth Venture Partners, LLC | 146,428 | $306.0K | 0.18% |
| Citadel Advisors LLC | 11,577 | $24.2K | 0.00% |
Sold out (1)
Institutions that held BioCardia, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Dimensional Fund Advisors LP | 27,407 | $53.0K |